BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29060930)

  • 1. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.
    Meng Q; Xiang L; Fu J; Chu X; Wang C; Yan B
    Oncotarget; 2017 Jun; 8(23):37321-37331. PubMed ID: 28418879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer.
    Qu M; Li L; Zheng WC
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3384-3388. PubMed ID: 28829504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
    Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
    Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
    Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
    Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
    J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
    Su Z; Zhao J; Rong Z; Geng W; Wang Z
    Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.